Immunovant, Inc.IMVTNASDAQ
Loading
SG&A Expenses Over TimeStrong
Percentile Rank100
3Y CAGR+18.1%
5Y CAGR+14.9%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+18.1%/yr
vs +1709.4%/yr prior
5Y CAGR
+14.9%/yr
Recent acceleration
Acceleration
-1691.3pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
2x
Strong expansion
Streak
3 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $79.15M | +2.5% |
| 2025 | $77.23M | +34.8% |
| 2024 | $57.28M | +19.3% |
| 2023 | $48.02M | -11.4% |
| 2022 | $54.23M | +37.2% |
| 2021 | $39.51M | +236.9% |
| 2020 | $11.73M | +2618203.6% |
| 2019 | $448.00 | -100.0% |
| 2018 | $1.48M | - |